Towards clinical translation, we carefully reviewed existing substances and drugs targeting the IL-1β/IL-1R1/IL-1Ra pathway and HMGB1/TLR4 pathway and their effects on epilepsy models and patients. The gene discussed is TLR4; the disease is epilepsy.